X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1293) 1293
index medicus (1212) 1212
male (822) 822
ophthalmology (759) 759
female (743) 743
conjunctival neoplasms - pathology (631) 631
middle aged (608) 608
aged (579) 579
adult (507) 507
aged, 80 and over (298) 298
conjunctival neoplasms - drug therapy (287) 287
conjunctiva (274) 274
conjunctival neoplasms - therapy (270) 270
conjunctival neoplasms - surgery (243) 243
treatment outcome (228) 228
conjunctival neoplasms - diagnosis (213) 213
tumors (211) 211
retrospective studies (206) 206
combined modality therapy (172) 172
follow-up studies (170) 170
melanoma (170) 170
melanoma - pathology (170) 170
abridged index medicus (161) 161
biopsy (159) 159
carcinoma, squamous cell - pathology (154) 154
diagnosis, differential (140) 140
prognosis (136) 136
conjunctival neoplasms - radiotherapy (133) 133
eye neoplasms - pathology (131) 131
administration, topical (125) 125
cancer (121) 121
oncology (113) 113
radiotherapy (112) 112
adolescent (109) 109
melanoma - therapy (109) 109
surgery (109) 109
care and treatment (108) 108
squamous cell carcinoma (103) 103
antineoplastic agents - therapeutic use (102) 102
carcinoma in situ - pathology (102) 102
chemotherapy (102) 102
conjunctiva - pathology (102) 102
diagnosis (102) 102
carcinoma in situ - drug therapy (101) 101
neoplasm recurrence, local (95) 95
management (93) 93
malignant-melanoma (91) 91
child (90) 90
cryotherapy (90) 90
carcinoma, squamous cell - surgery (89) 89
eyelid neoplasms - pathology (89) 89
corneal diseases - pathology (88) 88
metastasis (86) 86
eye neoplasms - drug therapy (85) 85
mitomycin - therapeutic use (83) 83
therapy (83) 83
corneal diseases - drug therapy (80) 80
eye (80) 80
neoplasia (80) 80
conjunctival melanoma (79) 79
neoplasm invasiveness (78) 78
carcinoma, squamous cell - drug therapy (76) 76
lymphomas (74) 74
mitomycin - administration & dosage (74) 74
neoplasm staging (74) 74
primary acquired melanosis (74) 74
orbital neoplasms - pathology (73) 73
antibiotics, antineoplastic - therapeutic use (70) 70
eye neoplasms - therapy (69) 69
immunohistochemistry (69) 69
melanoma - surgery (69) 69
lymphoma, b-cell, marginal zone - pathology (68) 68
interferon-alpha - therapeutic use (67) 67
ophthalmologic surgical procedures (67) 67
carcinoma, squamous cell - therapy (66) 66
conjunctival (66) 66
risk factors (66) 66
conjunctival neoplasms - etiology (65) 65
eye diseases (65) 65
animals (63) 63
medicine & public health (62) 62
recurrence (61) 61
antineoplastic combined chemotherapy protocols - therapeutic use (60) 60
patients (60) 60
squamous-cell carcinoma (60) 60
carcinoma, squamous cell - diagnosis (59) 59
cell carcinoma (59) 59
mitomycin-c (59) 59
ophthalmic solutions (59) 59
antineoplastic agents - administration & dosage (58) 58
melanoma - diagnosis (58) 58
research (58) 58
tomography, x-ray computed (58) 58
cornea (57) 57
interferon-alpha - administration & dosage (57) 57
lymphoma (57) 57
eye neoplasms - surgery (56) 56
carcinoma (54) 54
conjunctival intraepithelial neoplasia (54) 54
young adult (54) 54
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1222) 1222
German (75) 75
French (51) 51
Spanish (20) 20
Russian (12) 12
Portuguese (8) 8
Chinese (6) 6
Japanese (6) 6
Polish (6) 6
Romanian (3) 3
Italian (2) 2
Croatian (1) 1
Danish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Korean (1) 1
Norwegian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA Ophthalmology, ISSN 2168-6165, 07/2014, Volume 132, Issue 7, pp. 851 - 858
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 12/2017, Volume 135, Issue 12, pp. 1367 - 1374
Journal Article
Ophthalmology, ISSN 0161-6420, 2014, Volume 121, Issue 5, pp. 994 - 1000
Purpose Treatment for ocular surface squamous neoplasia (OSSN) has historically been surgery, but nonsurgical interventions are increasingly used. Treatment... 
AMERICAN-JOINT-COMMITTEE | CORNEAL | SOLID TUMORS | MITOMYCIN-C | OPHTHALMOLOGY | TERM-FOLLOW-UP | CANCER-CLASSIFICATION | CONJUNCTIVAL INTRAEPITHELIAL NEOPLASIA | HUMAN-PAPILLOMAVIRUS | TOPICAL INTERFERON-ALPHA-2B | CELL CARCINOMA | Recombinant Proteins - therapeutic use | Corneal Diseases - therapy | Conjunctival Neoplasms - drug therapy | Conjunctival Neoplasms - surgery | Carcinoma in Situ - drug therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Squamous Cell - surgery | Male | Antineoplastic Agents - therapeutic use | Eye Neoplasms - therapy | Eye Neoplasms - surgery | Case-Control Studies | Ophthalmologic Surgical Procedures | Eye Neoplasms - drug therapy | Carcinoma in Situ - surgery | Aged, 80 and over | Ophthalmic Solutions | Adult | Female | Corneal Diseases - pathology | Postoperative Complications | Visual Acuity - physiology | Carcinoma in Situ - pathology | Risk Factors | Eye Neoplasms - pathology | Interferon-alpha - therapeutic use | Carcinoma, Squamous Cell - therapy | Corneal Diseases - drug therapy | Treatment Outcome | Neoplasm Recurrence, Local - diagnosis | Carcinoma in Situ - therapy | Conjunctival Neoplasms - therapy | Conjunctival Neoplasms - pathology | Corneal Diseases - surgery | Carcinoma, Squamous Cell - drug therapy | Aged | Neoplasm Staging | Cryotherapy | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 01/2006, Volume 107, Issue 2, pp. 467 - 472
Non-Hodgkin lymphomas are among the most common primary tumors occurring in the ocular adnexa. Herein, we present a 14-year single-institution experience in 62... 
HEALTH-ORGANIZATION CLASSIFICATION | BORRELIA-BURGDORFERI INFECTION | SURVIVAL | B-CELL LYMPHOMA | PROGNOSIS | MARGINAL ZONE | TRACHOMATIS | TISSUE LYMPHOMA | RADIOTHERAPY | HEMATOLOGY | MALT LYMPHOMA | Prognosis | Psittacosis - microbiology | Psittacosis - pathology | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Lymphoma, B-Cell, Marginal Zone - therapy | Male | Lacrimal Apparatus Diseases - therapy | Eye Neoplasms - therapy | Lymphoma, Large B-Cell, Diffuse - therapy | Orbital Neoplasms - microbiology | Orbital Neoplasms - therapy | Aged, 80 and over | Adult | Female | Lymphoma, B-Cell, Marginal Zone - pathology | Conjunctival Neoplasms - microbiology | Lymphoma, B-Cell, Marginal Zone - microbiology | Lacrimal Apparatus Diseases - microbiology | Lymphoma, Large B-Cell, Diffuse - pathology | Chlamydophila psittaci - isolation & purification | Risk Factors | Eye Neoplasms - pathology | Orbital Neoplasms - pathology | Survival Rate | Treatment Outcome | Combined Modality Therapy | Chlamydophila psittaci - genetics | Conjunctival Neoplasms - therapy | Lymphoma, Large B-Cell, Diffuse - microbiology | Conjunctival Neoplasms - pathology | Psittacosis - therapy | Lymphoma, B-Cell - microbiology | Lymphoma, B-Cell - pathology | Eye Neoplasms - microbiology | Aged | Neoplasm Staging | Lacrimal Apparatus Diseases - pathology | Cohort Studies | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article
Oncotarget, ISSN 1949-2553, 2015, Volume 6, Issue 28, pp. 25868 - 25882
Objectives: Recently, recurrent mutations in regulatory DNA regions, such as promoter mutations in the TERT gene were identified in melanoma. Subsequently,... 
Promoter mutations | Melanoma | SDHD | SURVIVAL | LANDSCAPE | melanoma | CANCER | CELL BIOLOGY | CONJUNCTIVAL | INHIBITION | GENE | BRAF MUTATIONS | GERMLINE MUTATIONS | COMPLEX II | ANTI-PD-1 | promoter mutations | Uveal Neoplasms - therapy | Humans | Middle Aged | Male | Uveal Neoplasms - enzymology | Neoplasms, Radiation-Induced - mortality | Young Adult | Neoplasms, Radiation-Induced - genetics | Sunlight - adverse effects | Skin Neoplasms - enzymology | Time Factors | DNA Mutational Analysis | Base Sequence | Aged, 80 and over | Proto-Oncogene Proteins c-ets - metabolism | Binding Sites | Child | Conjunctival Neoplasms - enzymology | Genetic Predisposition to Disease | Skin Neoplasms - therapy | Melanoma - pathology | Ultraviolet Rays - adverse effects | Neoplasms, Radiation-Induced - therapy | Phenotype | Succinate Dehydrogenase - genetics | Adolescent | Conjunctival Neoplasms - genetics | Biomarkers, Tumor - genetics | Mutation | Melanoma - mortality | Neoplasms, Radiation-Induced - enzymology | Prognosis | Gene Expression Regulation, Neoplastic | Melanoma - enzymology | Molecular Sequence Data | Melanoma - genetics | Skin Neoplasms - mortality | Adult | Female | Neoplasms, Radiation-Induced - pathology | Skin Neoplasms - pathology | Promoter Regions, Genetic | Uveal Neoplasms - genetics | Uveal Neoplasms - pathology | Kaplan-Meier Estimate | Conjunctival Neoplasms - therapy | Conjunctival Neoplasms - pathology | Gene Expression Regulation, Enzymologic | Skin Neoplasms - genetics | Uveal Neoplasms - mortality | Conjunctival Neoplasms - mortality | Protein Binding | Aged | Melanoma - therapy | Index Medicus
Journal Article
Ophthalmology, ISSN 0161-6420, 2008, Volume 115, Issue 8, pp. 1297 - 1302.e1
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 03/2015, Volume 93, Issue 2, pp. 184 - 191
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 04/2016, Volume 134, Issue 4, pp. 406 - 414
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 03/2013, Volume 91, Issue 2, pp. 163 - 169
Journal Article
Journal Article